The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Xcyte Therapies, Inc.

Xcyte Therapies, Inc.
 PROFILE
Xcyte Therapies is issuing a T-cell call to arms. The development-stage company is working on therapy technology, called Xcellerate, to spur the immune system into action. Drawing disease-fighting T-cells from the patient's blood, the Xcellerate system activates the cells outside the body and re-injects them intravenously; the T-cells may then be used to treat diseases such as HIV and cancer and support immune systems weakened by chemotherapy, post-transplant suppression therapies, congenital disorders, and age. The therapy can be performed on an outpatient basis in 30 minutes and could be used in conjunction with other therapies, thanks to its low toxicity. CEO Ronald Berenson founded the firm in 1996.

 COMPETITION
AVANT Immunotherapeutics, Inc. (AVAN)
Alexion Pharmaceuticals, Inc. (ALXN)
CEL-SCI Corporation (CVM)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 0.00
Employees: 64
Revenue per employee: $0.00

 KEY PEOPLE
• Ronald J. Berenson
    CEO
• Kathi L. Cordova
    CFO

 CONTACT INFO
1124 Columbia St., Ste. 130
Seattle, WA 98104
US
Phone: 206-262-6200
Fax: 206-262-0900
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001